THIRD ROCK VENTURES
Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Third Rock Ventures believes in the companies we start and makes significant initial investments, which are frequently supplemented by strategic collaborations, to help our firms progress in life-changing medicines, technologies, and diagnostics.
THIRD ROCK VENTURES
Industry:
Biotechnology Health Care Medical Device
Founded:
2007-01-01
Status:
Active
Contact:
(415) 766-3600
Technology used in webpage:
Domain Not Resolving Amazon Pound Sterling Cloudflare ASP.NET IIS Japanese Yen COVID-19 Ruby On Rails Token ASP.NET 4.0
Similar Organizations
Blue Belt Technologies
Blue Belt Technologies is a medical device company that focuses on technology and capabilities of surgical instrumentation.
Creative Ventures
Creative Ventures is a deep tech venture firm investing in early-stage companies solving humanity’s most critical crises.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Telcare
Telcare develops machine-2-machine cellular technology that wirelessly connects patients and physicians to cure chronic illnesses.
Thar Pharmaceuticals
Thar Pharmaceuticals identifies and develops prescription drugs that solve clinical opportunities such as efficacy, absorption and safety.
X-Nav Technologies
X-Nav Technologies is a medical device company that develops surgical products for the dental market.
Current Advisors List
Board_member
2013-01-01
Advisor
2012-01-01
Advisor
Board_member
Current Employees Featured
Cynthia Clayton Vice President, Communications & Investor Relations @ Third Rock Ventures
Vice President, Communications & Investor Relations
2019-05-01
Andrew Warren Associate @ Third Rock Ventures
Associate
2018-09-01
John Maraganore Venture Partner @ Third Rock Ventures
Venture Partner
2013-01-01
Tim Funnell Principal @ Third Rock Ventures
Principal
Richard Ransohoff Venture Partner @ Third Rock Ventures
Venture Partner
2019-05-01
Lorence Kim Venture Partner @ Third Rock Ventures
Venture Partner
2020-09-01
Mark D. Angelino Venture Partner @ Third Rock Ventures
Venture Partner
2021-03-01
Jeffrey Finer Venture Partner @ Third Rock Ventures
Venture Partner
2016-01-01
Craig Muir Venture Partner @ Third Rock Ventures
Venture Partner
2007-09-01
Philip Reilly Venture Partner @ Third Rock Ventures
Venture Partner
2008-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-06-18 | Marea Therapeutics | Third Rock Ventures investment in Series B - Marea Therapeutics | 190 M USD |
| 2024-06-18 | Marea Therapeutics | Third Rock Ventures investment in Series A - Marea Therapeutics | 65.42 M USD |
| 2024-05-28 | CARGO Therapeutics | Third Rock Ventures investment in Post-IPO Equity - CARGO Therapeutics | 110 M USD |
| 2024-04-16 | Asher Bio | Third Rock Ventures investment in Series C - Asher Bio | 55 M USD |
| 2024-04-09 | Seaport Therapeutics | Third Rock Ventures investment in Series A - Seaport Therapeutics | 100 M USD |
| 2024-03-20 | Clasp Therapeutics | Third Rock Ventures investment in Series A - Clasp Therapeutics | 150 M USD |
| 2023-12-14 | Synnovation Therapeutics | Third Rock Ventures investment in Series A - Synnovation Therapeutics | 102 M USD |
| 2023-12-07 | ARTBIO | Third Rock Ventures investment in Series A - ARTBIO | 90 M USD |
| 2023-11-02 | Terremoto Biosciences | Third Rock Ventures investment in Series B - Terremoto Biosciences | 175 M USD |
| 2023-08-23 | Rapport Therapeutics | Third Rock Ventures investment in Series B - Rapport Therapeutics | 150 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-25 | Third Rock Ventures Expands Senior Team with Seasoned Biotech Executives |
More informations about "Third Rock Ventures"
Third Rock Ventures - Wikipedia
Third Rock Ventures has raised $3.8 billion since it was created and invested in more than 60 companies, including Sage Therapeutics, Editas Medicine, Constellation Pharmaceuticals and …See details»
Approach - Thirdrockventures
Third Rock's mission is to be the preferred partner for entrepreneurs, investors, employees and industry to build great companies that discover and develop products that make a difference for the patients we serve. ... Organization. …See details»
Third Rock Ventures - Crunchbase Investor Profile
Third Rock Ventures has made several strategic moves recently. They have expanded their senior team by hiring seasoned biotech executives and added three new venture partners while promoting two others. Additionally, they sold …See details»
Third Rock Ventures Raises $1.1 Billion Fund VI
Boston – June 15, 2022 – Third Rock Ventures today announced the closing of Third Rock Ventures Fund VI, raising $1.1 billion. Fund VI will continue Third Rock’s core strategy to …See details»
Third Rock Ventures - Investments, Portfolio & Company Exits
Third Rock Ventures has made 46 diversity investments. Their most recent diversity investment was on May 28, 2024, when CARGO Therapeutics raised. obfuscated. ... Revolution …See details»
Who Is Third Rock Ventures? An Overview - Excedr
Third Rock Ventures Builds Sustainable Life Science Companies. Founded in 2007 and headquartered in Boston, Massachusetts, Third Rock Ventures, LLC is a venture capital firm with a portfolio comprising more than 58 life science …See details»
Third Rock Ventures investment portfolio | PitchBook
Sep 9, 2024 Third Rock Ventures's latest investment was on 26-Nov-2024 in Maze Therapeutics, a company within the Drug Discovery industry. Data Transparency. Meet our …See details»
Third Rock Ventures - LinkedIn
Third Rock Ventures | 45,496 followers on LinkedIn. We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business …See details»
Third Rock Ventures Portfolio Companies - Crunchbase
Third Rock Ventures invests in transformational life science companies that show high growth potential. This list of organizations invested in by Third Rock Ventures provides data on their …See details»
Third Rock Ventures | StartupHub.ai
Third Rock Ventures, founded in 2007, discovers, launches, and builds companies at the intersection of science, strategy, business, and medicine. They invest in innovative ideasSee details»
Third Rock Ventures, LLC - MassBio
Third Rock Ventures L.L.C. is a premier venture firm focused on life sciences investing and launching companies that make a difference in people’s lives. Collaborating with …See details»
Third Rock Ventures CEO and Key Executive Team | Craft.co
Third Rock Ventures's Partner, Chief Operating Officer is Kevin Gillis. Other executives include Alison Connors, Chief Financial Officer; Chris Robinson, Chief Talent Officer and 19 others. …See details»
Third Rock Ventures Company Profile - Craft
Third Rock Ventures has 5 employees across 2 locations. See insights on Third Rock Ventures including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
THIRD ROCK VENTURES, LLC | Reuters
6 days ago Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its paperwork for a U.S. initial public offering (IPO) filing on …See details»
Third Rock Ventures - Contacts, Employees, Board Members
Third Rock Ventures has 46 current employee profiles, including Vice President, Communications & Investor Relations Cynthia Clayton. Third Rock Ventures has 4 board members and …See details»
Third Rock-Backed Maze Therapeutics Reveals Profit in US IPO Filing
6 days ago (Reuters) - Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its paperwork for a U.S. initial public …See details»
21.1 - SEC.gov
Dec 31, 2019 Subsidiaries of BBX Capital Corporation. Jurisdiction of  Organization. Woodbridge Holdings Corporation . Florida. BBX Capital Florida, LLC. Florida. Eden Services ...See details»
Corporate Registry Notices -- September 20, 2018 - BC Laws
THIRD ROCK TELECOM INC. at 03:55 PM Pacific Time: 1179064: TOLFINTRY ENTERTAINMENT INC. at 09:33 PM Pacific Time: 1179024: TOP SPIN FOODS LTD. at …See details»
7r Ventures | FinTech, Venture Capital - Link Stock
7r Ventures | FinTech, Venture Capital | Founded 2017-01-01. 7r Ventures is a Technology holding company. They design, build and invest in new cash-flow driven tech companies that …See details»
Biddle Real Estate Ventures moves construction forward on …
May 8, 2023 Peter Chavkin, Managing Member, Biddle Real Estate Ventures (BREV), said, “We’re grateful for the continued support and leadership of the Prince William County Board of …See details»